Transcription of WARNINGS AND PRECAUTIONS----------------- - …
{{id}} {{{paragraph}}}
US-11093. HIGHLIGHTS OF prescribing information ---------------------------------WARNING S AND precautions ----------------------------- ---- These highlights do not include all the information needed to use BEVESPI AEROSPHERE Do not initiate in acutely deteriorating COPD or to treat acute symptoms. ( ). safely and effectively. See full prescribing information for BEVESPI AEROSPHERE. Do not use in combination with an additional medicine containing a LABA because of BEVESPI AEROSPHERE (glycopyrrolate and formoterol fumarate) inhalation aerosol, risk of overdose. ( , ). for oral inhalation use If paradoxical bronchospasm occurs, discontinue BEVESPI AEROSPHERE and Initial Approval: 2016 institute alternative therapy. ( ). Use with caution in patients with cardiovascular disorders. ( ). WARNING: ASTHMA-RELATED DEATH Use with caution in patients with convulsive disorders, thyrotoxicosis, diabetes See full prescribing information for complete boxed warning.
HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use BEVESPI AEROSPHERE safely and effectively.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}